Raloxifene is a selective estrogen receptor modulator used for prevention and treatment of postmenopausal osteoporosis. It acts as an agonist of estrogen in bone but an antagonist in other tissues ...

Although chronic kidney disease (CKD) is associated with an increased likelihood of osteoporosis, the efficacy and safety of therapies for osteoporosis in women with CKD remain unclear. Ishani et al.